Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million.
Egged on by professed Christians, the Department of Defense and Department of the Air Force appear to be turning a blind eye to the facts surrounding a vaccine recently approved by the FDA for emergency use.